MCDONOUGH JOHN (President & CEO) sold 10.1% of their position (57.42K shares) of T2 BIOSYSTEMS, INC. on the open market
Open‑market sale worth $66.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/27/2020ACC: 0000899243-20-002026
DirectorOfficer· President & CEO
Since Jul 2018
-57.42K
Net shares
Net seller
$66.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
57.42K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−57.42K
Price / share
$1.15
Trade value
$66.03K
% of position
10.1%
1/23/2020
570.28K→512.87K
Total
Net shares
−57.42K
Net value
-$66.03K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/23/2020 | S · Sale | −57.42K | $1.15 | $66.03K | 10.1% | 570.28K | 512.87K |
| Total | −57.42K | -$66.03K | ||||||
Derivative Transactions0
No derivative transactions reported